Approved IV drug reduces lupus symptoms, clinical trial finds

An already-approved IV drug significantly reduces the symptoms of lupus, a new clinical trial showed. More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant improvement in their symptoms ...

Brain imaging offers insights into cochlear implant success

A cochlear implant is a complex electronic device that can improve hearing in individuals with severe to profound hearing loss. While the implant does not restore normal hearing and differs from hearing aids, which amplify ...

page 37 from 40